|
Delayed
Japan Exchange
02:30:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 1,101.50 JPY | +7.25% |
|
+5.31% | -33.50% |
| 08-12 | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
| 08-12 | PeptiDream Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEPTIDREAM INC. | Bio Therapeutic Drugs | +7.25% | +5.31% | -33.50% | -29.12% | -72.18% | 833M |  |  | |
- Stock Market
- Stocks
- 4587 Stock
- Charts PeptiDream Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
